New User? Click here to register

New treatments and perspectives in metastatic TNBC with PARP Inhibitors.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Benjamin VERRET
Oncologist, Villejuif, France

At what stage do you integrate liquid biopsy into breast cancer management? How early?
Simon NAYLER
pathologist, Johanesburgh, South Africa
What are the goals of AROME?
Jospeh GLIGOROV
oncologist, Paris, France
Comment a évoluée l’offre de soin dans le cancer du sein dans les pays émergents ces dernières années ?
Yazid BELKACEMI

Oncologue-Radiothérapeute, Créteil, France
What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?
Hassan GHAZAL
oncologist, Dubai
Breast cancer predisposition genes and implication for screening management.
Luc ROTENBERG
Radiologist, Neuilly Sur Seine, France